pI: 6.0277 |
Length (AA): 1519 |
MW (Da): 161772 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
784 | 976 | 1ouv (A) | 70 | 275 | 25.00 | 0.000029 | 1 | 0.41 | -0.36 |
921 | 1165 | 1ouv (A) | 40 | 281 | 15.00 | 0.000036 | 0.75 | 0.31 | -0.02 |
979 | 1125 | 2fo7 (A) | 1 | 135 | 17.00 | 0.0000051 | 0.23 | 0.19 | -0.63 |
1168 | 1257 | 1na3 (A) | 2 | 85 | 23.00 | 0.00000000019 | 0.14 | 0.38 | -1.78 |
855 | 1024 | 1ouv (A) | 70 | 237 | 25.00 | 0.00044 | 1 | 0.466816 | -0.24 |
1363 | 1452 | 2kr0 (A) | 198 | 295 | 34.00 | 0.034 | 0.15 | 0.16115 | 1.64 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite, ME49 merozoite. | Gregory Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite. | Gregory |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_127091)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G73570 | HCP-like superfamily protein |
Arabidopsis thaliana | AT1G18260 | Hrd3/Sel1L-like protein |
Babesia bovis | BBOV_III007900 | conserved hypothetical protein |
Brugia malayi | Bm1_45745 | sel-1 |
Candida albicans | CaO19.1191 | degradation of Hmg CoA reductase isozyme Hmg2 |
Candida albicans | CaO19.8782 | degradation of Hmg CoA reductase isozyme Hmg2 |
Caenorhabditis elegans | CELE_F45D3.5 | Protein SEL-1 |
Cryptosporidium hominis | Chro.60367 | sel-1 protein |
Cryptosporidium parvum | cgd6_3170 | Sel1 protein, putative |
Dictyostelium discoideum | DDB_G0269430 | hypothetical protein |
Dictyostelium discoideum | DDB_G0269432 | hypothetical protein |
Drosophila melanogaster | Dmel_CG10221 | CG10221 gene product from transcript CG10221-RB |
Escherichia coli | b0644 | Sel1 family TPR-like repeat protein |
Echinococcus granulosus | EgrG_000104800 | protein sel 1 1 |
Entamoeba histolytica | EHI_178100 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000104800 | protein sel 1 1 |
Homo sapiens | ENSG00000071537 | sel-1 suppressor of lin-12-like (C. elegans) |
Homo sapiens | ENSG00000101251 | sel-1 suppressor of lin-12-like 2 (C. elegans) |
Leishmania braziliensis | LbrM.07.0650 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_070640.1 | Sel1 repeat, putative |
Leishmania infantum | LinJ.07.0640 | hypothetical protein, conserved |
Leishmania infantum | LinJ.07.0650 | hypothetical protein, conserved |
Leishmania major | LmjF.07.0590 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.07.0590 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_08490 | Sel1l protein |
Mus musculus | ENSMUSG00000020964 | sel-1 suppressor of lin-12-like (C. elegans) |
Mus musculus | ENSMUSG00000074764 | sel-1 suppressor of lin-12-like 2 (C. elegans) |
Neospora caninum | NCLIV_008780 | Sel1 domain protein repeat-containing protein, related |
Neospora caninum | NCLIV_056970 | hypothetical protein, conserved |
Oryza sativa | 4332310 | Os03g0259300 |
Plasmodium berghei | PBANKA_0410800 | ubiquitin-protein ligase, putative |
Plasmodium berghei | PBANKA_1312200 | ubiquitin-protein ligase, putative |
Plasmodium falciparum | PF3D7_0313100 | ubiquitin-protein ligase, putative |
Plasmodium falciparum | PF3D7_1448400 | ubiquitin-protein ligase, putative |
Plasmodium knowlesi | PKNH_0829100 | ubiquitin-protein ligase, putative |
Plasmodium knowlesi | PKNH_1233700 | ubiquitin-protein ligase, putative |
Plasmodium vivax | PVX_118065 | ubiquitin-protein ligase, putative |
Plasmodium vivax | PVX_119750 | ubiquitin-protein ligase, putative |
Plasmodium yoelii | PY04510 | hypothetical protein |
Plasmodium yoelii | PY05112 | hypothetical protein |
Saccharomyces cerevisiae | YLR207W | ubiquitin ligase complex subunit HRD3 |
Schistosoma japonicum | Sjp_0038630 | ko:K07126 sel-1 suppressor of lin-12-like, putative |
Schistosoma japonicum | Sjp_0317080 | expressed protein |
Schistosoma mansoni | Smp_133270 | sel-1-like protein sel-1l |
Schmidtea mediterranea | mk4.007698.00 | Sel-1-like protein, sel-1l |
Schmidtea mediterranea | mk4.010481.01 | |
Trypanosoma brucei gambiense | Tbg972.8.790 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.1250 | Sel1 repeat, putative |
Trypanosoma congolense | TcIL3000_8_920 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_0_21740 | Sel1 repeat, putative |
Trypanosoma cruzi | TcCLB.508543.150 | Sel1 repeat, putative |
Trypanosoma cruzi | TcCLB.506401.230 | Sel1 repeat, putative |
Toxoplasma gondii | TGME49_254490 | Sel1 repeat-containing protein |
Toxoplasma gondii | TGME49_313690 | Sel1 repeat-containing protein |
Theileria parva | TP04_0695 | hypothetical protein |
Theileria parva | TP04_0694 | hypothetical protein |
Trichomonas vaginalis | TVAG_242010 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1250 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.1250 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0644 | Escherichia coli | non-essential | goodall |
PBANKA_0410800 | Plasmodium berghei | Essential | plasmo |
TGME49_313690 | Toxoplasma gondii | Probably essential | sidik |
TGME49_254490 this record | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.4